Breast Cancer
HER 2 Negative Breast Cancer
Female, 45 years
Patient Internal ID: 495720
ICD-10 code
C50.5 Malignant Neoplasm of Lower Outer Quadrant of Breast
Diagnosis (Incl. Metastases/Stage) and Year
June 2022
Invasive Poorly Differentiated Ductal Carcinoma of the Right Breast G3 pT2pN0(sn)M0 Stage II A, LVI-0, ER (+), PR (-), HER2(1+), Ki67 – 3% (up to 10% in Hot Spots).
Previous Treatment
Surgery, Hormone Therapy (Tamoxifen), Radiation Therapy.
Prognosis and Survival Expectation
Estrogen-Receptor Positive Breast Cancer has a median overall survival (OS) of 37 months. The overall survival rate of Breast Cancer patients on Estrogen Positive Receptors was 41.51%.
Treatment Provided
Autologous DCV (5 doses) and CIK (4 doses) over a period of 4 months.
Patient Survival/Condition and Year
Date of Review: 30/12/2023
The patient has survived for 18 months since the diagnosis so far. No signs of disease progression.
The patient continues treatment with Tamoxifen and has regular follow-up visits.
